Orchestra Medical Ventures (formerly Accelerated Technologies Partners) is an investment firm that employs a proprietary and innovative
Orchestra Medical Ventures (formerly Accelerated Technologies Partners) is an investment firm that employs a proprietary and innovative strategy to create, build and invest in medical technology companies intended to generate substantial clinical value and superior investor returns.Specifically, the Orchestra Strategy is based on coordinated collaboration with multi-disciplinary teams comprised of world-leading physicians and experienced technical and business experts. Working with these teams, Orchestra immerses itself into selected high-value, high-need clinical sectors in order to identify and analyze important unmet clinical needs that provide significant opportunities for technology innovations that can improve outcomes while reducing costs and complications. With these opportunities in mind, Orchestra and its sector-specific teams then work to conceive or source and then develop an optimal device solution to address such targeted unmet need.The Orchestra Strategy has been successfully pursued since 2000 through a predecessor medical device accelerator called Accelerated Technologies, Inc. ("ATI"), which continues to be operated by Orchestra. Orchestra's distinctive aproach is designed to significantly improve the likelihood of success of investing in medical technology innovation by aligning the interests and harnessing the collective talent of physicians, management and investors from inception through value creation and realization.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 1, 2016
Motus GI
|
Series Unknown | $30M | Biotechnology | — |